Stryker Corp (SYK)
330.90
+5.40
(+1.66%)
USD |
NYSE |
May 07, 11:54
Stryker Cash from Investing (TTM): -1.238B for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -1.238B |
December 31, 2023 | -962.00M |
September 30, 2023 | -972.00M |
June 30, 2023 | -755.00M |
March 31, 2023 | -374.00M |
December 31, 2022 | -2.924B |
September 30, 2022 | -3.076B |
June 30, 2022 | -3.395B |
March 31, 2022 | -3.445B |
December 31, 2021 | -859.00M |
September 30, 2021 | -4.897B |
June 30, 2021 | -4.719B |
March 31, 2021 | -4.634B |
December 31, 2020 | -4.701B |
September 30, 2020 | -1.068B |
June 30, 2020 | -1.185B |
March 31, 2020 | -1.315B |
December 31, 2019 | -1.455B |
September 30, 2019 | -2.364B |
June 30, 2019 | -2.334B |
March 31, 2019 | -2.311B |
December 31, 2018 | -2.857B |
September 30, 2018 | -1.689B |
June 30, 2018 | -2.348B |
March 31, 2018 | -2.316B |
Date | Value |
---|---|
December 31, 2017 | -1.613B |
September 30, 2017 | -1.33B |
June 30, 2017 | -617.00M |
March 31, 2017 | -4.394B |
December 31, 2016 | -4.191B |
September 30, 2016 | -4.599B |
June 30, 2016 | -4.182B |
March 31, 2016 | 1.687B |
December 31, 2015 | 1.956B |
September 30, 2015 | 2.453B |
June 30, 2015 | 1.714B |
March 31, 2015 | -1.201B |
December 31, 2014 | -1.878B |
September 30, 2014 | -2.081B |
June 30, 2014 | -2.025B |
March 31, 2014 | -2.208B |
December 31, 2013 | -2.217B |
September 30, 2013 | -2.495B |
June 30, 2013 | -2.555B |
March 31, 2013 | -973.00M |
December 31, 2012 | -736.00M |
September 30, 2012 | -547.00M |
June 30, 2012 | -616.00M |
March 31, 2012 | -1.38B |
December 31, 2011 | -2.135B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.897B
Minimum
Sep 2021
-374.00M
Maximum
Mar 2023
-2.334B
Average
-1.894B
Median
Cash from Investing (TTM) Benchmarks
Boston Scientific Corp | -2.375B |
Haemonetics Corp | -327.34M |
Abbott Laboratories | -3.096B |
Zimmer Biomet Holdings Inc | -824.50M |
ResMed Inc | -269.80M |